Adria Cimino

Adria Cimino


Adria Cimino grew up with her nose in a book and a love of storytelling. By a twist of fate, she started her career writing about biotech in Boston and discovered that each company is the source of many fascinating stories. Prior to joining The Fool as a contract writer focused on healthcare and consumer goods, Adria covered the stock market for Bloomberg News in Paris. When she’s not analyzing companies, she can be found writing fiction or trying to speak French as well as her 9-year-old daughter.

Recent articles

Is Mylan Stock a Buy?

Mylan’s planned combination with Upjohn is a bright spot for investors, but the difficulties of the U.S. generic-drug market remain a potential obstacle.

3 Stocks Driving the Future of Retail

The RealReal, Stitch Fix, and Target appeal to the issues most important to today’s shoppers. That will make them the success stories of the future.

3 Keys to Success in Retail in 2020

Buy online/pickup in store, omnichannel experiences, and inventory control are three ways retailers can strengthen their performance -- in earnings reports and on the market.

Will Beyond Meat Get Nibbled to Death?

Impossible Foods is just one rival that will soon serve up more plant-based offerings, and that might take a bite out of Beyond Meat’s margins.